MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$63,200K
EPS
-$0.61
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
57,785
49,232
31,917*
39,951
General and administrative
9,394
8,754
6,169*
5,926
Total operating expenses
67,179
57,986
38,086
45,877
Loss from operations
-67,179
-57,986
-38,086*
-45,877
Interest income
4,507
4,776
4,689*
3,648
Other (gain) income
-528
121
-52*
12
Total other income
3,979
4,897
4,637*
3,660
Net loss
-63,200
-53,089
-33,449
-42,217
Basic EPS
-0.61
-0.52
-0.373
-0.49
Diluted EPS
-0.61
-0.52
-0.373
-0.49
Basic Average Shares
104,453,732
102,800,098
89,788,434
85,732,221
Diluted Average Shares
104,453,732
102,800,098
89,788,434
85,732,221
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$4,507K
(11.50%↑ Y/Y)
Net loss
-$63,200K
(-44.34%↓ Y/Y)
Total other income
$3,979K
(-2.48%↓ Y/Y)
Other (gain) income
-$528K
(-1489.47%↓ Y/Y)
Loss from operations
-$67,179K
(-40.35%↓ Y/Y)
Total operating
expenses
$67,179K
(40.35%↑ Y/Y)
Research and development
$57,785K
(31.62%↑ Y/Y)
General and
administrative
$9,394K
(137.10%↑ Y/Y)
Buy us a coffee
Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (OLMA)